Medicared For All Logo

Robert Gillespie in San Diego, California

Home California San Diego

Robert Gillespie has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 16899 W Bernardo Dr in San Diego, California.

They're a part of the: Sharp Rees-stealy Medical Group Inc medical group which has around 773 members. You can call their office at 858-499-2600 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Chicago, Pritzker School Of Medicine and graduated in 1986 (around 38 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Robert L Gillespie Office Phone and Directions

Robert Gillespie
Sharp Rees-stealy Medical Group Inc
16899 W Bernardo Dr
San Diego, California 92127
858-499-2600


Patient Ratings
Please rate your experience with Robert Gillespie below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 858-499-2600


Enter a starting address:


Healthcare Info for Robert Gillespie

Medical School: University Of Chicago, Pritzker School Of Medicine
Graduation Year: 1986
The Primary Medical Specialty for Robert Gillespie is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 38
PAC (PECOS ID)#: 1254464639
NPI #: 1740290873
NPI Created On: 08/09/2006
NPI Last Updated Listed as: 06/19/2013
Primary Taxonomy Code: 207RC0000X
License Number:
G66094
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. 3d radiographic procedure
  2. Nuclear medicine study of vessels of heart using drugs or exercise single study
  3. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  4. Routine ekg using at least 12 leads including interpretation and report
  5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  6. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  7. Heart rhythm symptom-related interpretation of 24-hour ekg monitoring up to 30 days
  8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  9. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  10. Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
  11. Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
  12. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
  13. Heart muscle strain imaging
  14. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
  15. New patient office or other outpatient visit, typically 45 minutes
  16. Established patient office or other outpatient visit, typically 15 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Established patient office or other outpatient, visit typically 40 minutes
  19. Initial hospital inpatient care, typically 50 minutes per day
  20. Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $54

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 777567857

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: STRUCTURAL HEART

Name of Drug #1: WATCHMAN


Payments Total: $29

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768814592

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest


Payments Total: $49

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 836369823

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Coronary

Name of Drug #1: FFRct


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Speaker Fee

Record ID:: 829417585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Speaker Fee

Record ID:: 829764199

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Payments Total: $950

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Speaker Fee

Record ID:: 829909597

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Speaker Fee

Record ID:: 830032591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Payments Total: $300

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Speaker Fee

Record ID:: 830043401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30


Cardiovascular Disease (cardiology) Professionals in San Diego

4647 Zion Ave
San-diego, CA
Southern California Permanente Medical Group

9455 Clairemont Mesa Blvd
San-diego, CA
Southern California Permanente Medical Group

200 W Arbor Dr
San-diego, CA
Rady Children's Hospital - San Diego

3010 Children's Way
San-diego, CA
Rady Children's Hospital - San Diego

3020 Childrens Way Mc
San-diego, CA
Rady Children's Hospital - San Diego

8110 Birmingham Way Bldg
San-diego, CA
Rady Children's Hospital - San Diego

Providers in Sharp Rees-stealy Medical Group Inc

1.Ashkan Abedini

5525 Grossmont Ctr Dr
La Mesa Ca 91942-3009
Sharp Rees-stealy Medical Group Inc
Family Practice

2.Amy Abola

2600 Via De La Valle
Del Mar Ca 92014-1992
Sharp Rees-stealy Medical Group Inc
Family Practice

3.Amy Abola

2020 Genesee Ave
San Diego Ca 92123-4219
Sharp Rees-stealy Medical Group Inc
Family Practice

4.Amy Abola

16950 Via Tazon
San Diego Ca 92127-1607
Sharp Rees-stealy Medical Group Inc
Family Practice

5.Basil Abramowitz

10243 Genetic Ctr Dr
San Diego Ca 92121-6310
Sharp Rees-stealy Medical Group Inc
Family Practice

6.Mohamed Abu-qaoud

1400 E Palomar St
Chula Vista Ca 91913-1800
Sharp Rees-stealy Medical Group Inc
Internal Medicine

View all 773 members of Sharp Rees-stealy Medical Group Inc medical group